-
公开(公告)号：EP3333163A1
公开(公告)日：2018-06-13
申请号：EP16833140.3
申请日：2016-08-05
申请人： UBE Industries, Ltd.
发明人： KOMORI, Ken-ichi , NINOMIYA, Akishi , USHIYAMA, Shigeru , SHINOHARA, Masaru , ITO, Koji , KAWAGUCHI, Tetsuo , TOKUNAGA, Yasunori , KAWADA, Hiroyoshi , YAMADA, Haruka , SHIRAISHI, Yusuke , KOJIMA, Masahiro , ITO, Masaaki , KIMURA, Tomio
IPC分类号： C07D401/04 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/506 , A61K31/5377 , A61K31/695 , A61P3/10 , A61P13/12 , A61P43/00 , C07D401/14 , C07D403/04 , C07D405/14 , C07D413/14 , C07F7/18
CPC分类号： A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/506 , A61K31/5377 , A61K31/695 , C07D401/04 , C07D401/14 , C07D403/04 , C07D405/14 , C07D413/14 , C07F7/18 , Y02P20/55
摘要： The present invention provides a compound of general formula (I) (wherein, R 1 , X, p and q are as described in the present description and claims), or a pharmacologically acceptable salt thereof, and a pharmaceutical composition containing that compound.
-
公开(公告)号：EP3214086A1
公开(公告)日：2017-09-06
申请号：EP15855181.2
申请日：2015-10-30
申请人： Ube Industries, Ltd.
发明人： AGA, Yasuhiro , USHIYAMA, Shigeru , IWASE, Noriaki , KONO, Shigeyuki , SUNAMOTO, Hidetoshi , MATSUSHITA, Takashi , OGI, Sayaka , TANAKA, Masayuki , MATOYAMA, Masaaki , UMEZAKI, Satoshi , SHIRAISHI, Yusuke , ONUMA, Kazuhiro , KOJIMA, Masahiro , NISHIYAMA, Hayato , KIMURA, Tomio
CPC分类号： C07F7/10 , A61K31/695 , Y02P20/55
摘要： Provided is a compound represented by formula (I) or a pharmacologically acceptable salt thereof:
wherein L 1 is an optionally substituted C 1-6 alkylene group or the like, L 2 is a single bond or the like, L 3 is a single bond or the like, R 1 , R 2 , and R 3 are each independently an optionally substituted C 1-4 alkyl group or the like, R 4 is a hydrogen atom or the like, and R 5 is a hydrogen atom or the like.摘要翻译： 提供由式（I）表示的化合物或其药理学上可接受的盐：其中L 1是任选取代的C 1-6亚烷基等，L 2是单键等，L 3是单键等， R1，R2和R3各自独立地为任选取代的C1-4烷基等，R4为氢原子等，R5为氢原子等。
-
搜索结果
2 条记录 (耗时 0.022 秒)
